FTLF · XBRL financial data

Fitlife Brands financial statements, every fiscal year

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (FTLF's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024†Dec 31, 2024	FY 2025†Dec 31, 2025
Revenue	21,744	—	—	—	—	—
Cost of revenue	12,350	—	—	—	—	—
Cost of goods and services sold	12,574	15,409	16,769	31,268	36,389	50,005
Gross profit	9,537	12,504	12,034	21,432	28,080	31,453
Selling, general and administrative	—	6,215	6,267	12,161	9,972	14,036
General and administrative	3,047	3,651	—	—	—	—
Total operating expenses	5,191	6,274	6,333	13,882	14,961	21,391
Operating income (loss)	4,346	6,230	5,701	7,550	13,119	10,062
Interest income	9	—	—	—	69	98
Interest expense	15	—	0	1,025	1,367	1,863
Income tax expense (benefit)	(4,415)	1,298	1,393	1,707	2,887	1,903
Net income (loss)	8,825	5,410	4,429	5,296	8,984	6,326
Earnings per share, basic‡ USD per share	4.17	0.62	0.49	0.59	0.49	0.68
Earnings per share, diluted‡ USD per share	3.88	0.57	0.45	0.54	0.46	0.63
Weighted average shares, basic‡ thousands of shares	2,116	8,813	9,105	9	18,394	9,347
Weighted average shares, diluted‡ thousands of shares	2,275	9,603	9,949	10	19,796	9,977

‡ Per-share figures and share counts are adjusted for the 2-for-1 stock split (February 2025); filings made before it reported them unadjusted.
† Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/2 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (FTLF's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024†Dec 31, 2024	FY 2025†Dec 31, 2025
Cash and cash equivalents	6,336	9,897	13,277	1,139	4,468	1,646
Accounts receivable	1,797	945	705	2,046	1,626	8,765
Inventory	3,529	6,520	9,105	9,091	11,074	21,324
Prepaid and other current assets	52	322	116	639	898	1,334
Total current assets	11,754	17,684	23,203	14,693	18,143	33,069
Property and equipment, net	98	70	46	137	75	128
Right-of-use asset	208	158	103	121	412	682
Goodwill	225	358	358	13,294	13,022	19,393
Total assets	16,624	21,507	25,707	55,346	58,531	106,320
Accounts payable	3,246	2,880	2,995	3,261	4,067	6,911
Current portion of long-term debt	—	—	0	—	4,500	—
Total current liabilities	4,139	4,058	4,270	10,337	11,311	21,610
Long-term debt	—	—	0	15,509	8,550	—
Lease liability, non-current	158	103	49	51	331	272
Total liabilities	4,750	4,161	4,319	28,310	22,405	62,681
Retained earnings (accumulated deficit)	(18,552)	(13,142)	(8,713)	(3,417)	5,567	11,893
Total stockholders' equity	11,874	17,346	21,388	27,036	36,126	43,639
Total liabilities and equity	16,624	21,507	25,707	55,346	58,531	106,320
Common shares outstanding (cover page)‡ thousands of shares	10,241	9,112	8,892	9,196	18,437	9,391

‡ Per-share figures and share counts are adjusted for the 2-for-1 stock split (February 2025); filings made before it reported them unadjusted.
† Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/2 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (FTLF's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024†Dec 31, 2024	FY 2025†Dec 31, 2025
Net income (loss)	8,825	5,410	4,429	5,296	8,984	6,326
Stock-based compensation	29	—	—	—	—	—
Depreciation and amortization	38	59	66	94	108	420
Net cash from operating activities	5,721	4,480	4,130	4,220	9,610	7,439
Purchases of property and equipment	—	—	0	106	10	42
Net cash from investing activities	0	(529)	0	(35,993)	(10)	(42,542)
Share repurchases	171	444	779	0	—	—
Dividends paid	0	—	—	—	—	—
Proceeds from long-term debt	—	—	0	22,500	0	40,452
Repayments of long-term debt	—	—	0	2,375	7,000	—
Net cash from financing activities	350	(390)	(750)	20,296	(6,983)	32,086
Net change in cash	6,071	3,561	3,380	(11,379)	2,622	(2,874)

† Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/2 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Fitlife Brands	1,089	not reported	3,635*	9.4M	—	Q2 FY26 10-QJun 30, 2026
Immucell	8,860	7,186	3,019*	9.1M	—	Q2 FY26 10-QJun 30, 2026
Cue Biopharma	17,392	7,877	(29,004)*	7.3M	0.6 quarters	Q2 FY26 10-QJun 30, 2026
Avalo Therapeutics	85,382	not reported	(19,988)*	53.6M	20.0 quarters	Q2 FY26 10-QJun 30, 2026
Precision Biosciences	81,698	0	(15,132)*	27.9M	6.1 quarters	Q3 FY26 10-QSep 30, 2026
Opus Genetics	88,812	755	(11,950)*	83.2M	7.4 quarters	Q2 FY26 10-QJun 30, 2026
Acumen Pharmaceuticals	53,075	not reported	(26,653)*	72.3M	3.4 quarters	Q3 FY26 10-QSep 30, 2026
iBio	56,395	0*	(6,228)*	64.3M	14.1 quarters	Q4 FY26 10-KJun 30, 2026
Fortress Biotech	196,576	18,718	(59,277)*	33.3M	3.3 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.